- Home
- JFU vs DYAI Comparison
JFU vs DYAI Comparison
Compare JFU & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JFU | DYAI |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.6M | 32.5M |
| IPO Year | 2018 | 2003 |
Fundamental Metrics
Financial Performance| Metric | JFU | DYAI |
|---|---|---|
| Price | $2.30 | $1.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 2.1K | ★ 248.7K |
| Earning Date | 12-09-2022 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,090,345.00 |
| Revenue This Year | N/A | $122.79 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | $1.43 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.51 | $0.65 |
| 52 Week High | $9.48 | $1.35 |
Technical Indicators
Market Signals| Indicator | JFU | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 34.43 | 68.54 |
| Support Level | N/A | $0.76 |
| Resistance Level | $2.88 | $1.29 |
| Average True Range (ATR) | 0.11 | 0.12 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 76.66 |
Price Performance
Historical ComparisonAbout JFU 9F Inc.
9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.